Tilray shares pop 12% after getting approval to import pot to US for medical study
September 18, 2018 at 09:04 AM EDT
Shares of Canadian cannabis producer Tilray jumped more than 12 percent in premarket trading Tuesday after it announced approval from the Drug Enforcement Administration to import marijuana for medical research.
